• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组学与系统生物学方法在脂质紊乱研究中的应用

GENOMICS AND SYSTEMS BIOLOGY APPROACHES IN THE STUDY OF LIPID DISORDERS.

作者信息

Rodríguez Alejandra, Pajukanta Päivi

机构信息

Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA.

Molecular Biology Institute, University of California, Los Angeles, USA.

出版信息

Rev Invest Clin. 2018;70(5):217-223. doi: 10.24875/RIC.18002576.

DOI:10.24875/RIC.18002576
PMID:30307448
Abstract

Cardiovascular disease (CVD) is a broad definition for diseases of the heart and blood vessels with high mortality and morbidity worldwide. Atherosclerosis and hypertension are the most common causes of CVD, and multiple factors confer the susceptibility. Some of the predisposing factors are modifiable such as diet, smoking, and exercise, whereas others, including age, sex, and individual's genetic variations contributing to the CVD composition traits, are non-modifiable. This latter group includes serum lipid traits. High serum lipid levels, specifically high levels of serum low-density lipoprotein cholesterol and triglycerides, are well-established key risk factors of atherosclerosis. This review will discuss genomics and systems biology approaches in the study of common dyslipidemias. The non-Mendelian forms of dyslipidemias are highly complex, and the molecular mechanisms underlying these polygenic lipid disorders are estimated to involve hundreds of genes. Interactions between the different genes and environmental factors also contribute to the clinical outcomes; however, very little is known about these interactions and their molecular mechanisms. To better address the complex genetic architecture and multiple properties leading to high serum lipid levels, networks and systems approach combining information at genomic, transcriptomics, methylomics, proteomics, metabolomics, and phenome level are being developed, with the ultimate goal to elucidate the cascade of dynamic changes leading to CVD in humans. (REV INVEST CLIN. 2018;70:217-23).

摘要

心血管疾病(CVD)是一个广泛的定义,指的是心脏和血管疾病,在全球范围内具有高死亡率和高发病率。动脉粥样硬化和高血压是心血管疾病最常见的病因,多种因素导致易感性。一些诱发因素是可改变的,如饮食、吸烟和运动,而其他因素,包括年龄、性别以及导致心血管疾病构成特征的个体基因变异,则是不可改变的。后一组因素包括血脂特征。高血清脂质水平,特别是高血清低密度脂蛋白胆固醇和甘油三酯水平,是公认的动脉粥样硬化关键危险因素。本综述将讨论常见血脂异常研究中的基因组学和系统生物学方法。非孟德尔形式的血脂异常非常复杂,这些多基因脂质紊乱的分子机制估计涉及数百个基因。不同基因与环境因素之间的相互作用也会影响临床结果;然而,对于这些相互作用及其分子机制知之甚少。为了更好地解决导致高血清脂质水平的复杂遗传结构和多种特性,正在开发结合基因组、转录组、甲基组、蛋白质组、代谢组和表型水平信息的网络和系统方法,最终目标是阐明导致人类心血管疾病的动态变化级联。(《临床研究回顾》。2018年;70:217 - 23)

相似文献

1
GENOMICS AND SYSTEMS BIOLOGY APPROACHES IN THE STUDY OF LIPID DISORDERS.基因组学与系统生物学方法在脂质紊乱研究中的应用
Rev Invest Clin. 2018;70(5):217-223. doi: 10.24875/RIC.18002576.
2
Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.泰国3499名城市居民队列中血脂与死亡原因的关联:泰国发电管理局(EGAT)研究
Angiology. 2007;58(6):757-63. doi: 10.1177/0003319707304042.
3
Lipid profile parameters in Malaysian dyslipidemic patients.马来西亚血脂异常患者的血脂谱参数。
Kobe J Med Sci. 2011 Dec 15;57(2):E38-48.
4
Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.血脂异常与心血管疾病预防:根据脂质表型调整治疗方案
Curr Cardiol Rep. 2017 Jul;19(7):61. doi: 10.1007/s11886-017-0869-3.
5
Lipids and lipid management in diabetes.糖尿病中的脂质和脂质管理。
Best Pract Res Clin Endocrinol Metab. 2014 Jun;28(3):325-38. doi: 10.1016/j.beem.2013.12.001. Epub 2013 Dec 18.
6
Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy.脂质代谢与降脂治疗的新靶点
Can J Cardiol. 2017 Jul;33(7):872-882. doi: 10.1016/j.cjca.2016.12.019. Epub 2017 Jan 16.
7
How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention.基因组学如何实现血脂异常管理和心血管疾病预防的个体化。
Curr Cardiol Rep. 2018 Oct 17;20(12):138. doi: 10.1007/s11886-018-1079-3.
8
Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis).载脂蛋白组合与 MESA(动脉粥样硬化多民族研究)颈动脉内膜中层厚度和冠状动脉钙的相关性。
J Am Coll Cardiol. 2010 Sep 21;56(13):1034-41. doi: 10.1016/j.jacc.2010.01.073.
9
The role of cardiorespiratory fitness on plasma lipid levels.心肺适能对血浆脂质水平的作用。
Expert Rev Cardiovasc Ther. 2015 Nov;13(11):1177-83. doi: 10.1586/14779072.2015.1092384. Epub 2015 Oct 5.
10
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.管理他汀类药物治疗患者与高密度脂蛋白胆固醇和甘油三酯相关的残余心血管疾病风险:临床更新。
Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):799-807. doi: 10.1016/j.numecd.2013.05.002. Epub 2013 Aug 9.

引用本文的文献

1
Integrating systematic biological and proteomics strategies to explore the pharmacological mechanism of danshen yin modified on atherosclerosis.整合系统生物学和蛋白质组学策略,探索丹参饮干预动脉粥样硬化的药理机制。
J Cell Mol Med. 2020 Dec;24(23):13876-13898. doi: 10.1111/jcmm.15979. Epub 2020 Nov 2.
2
Neutrophil-Lymphocyte Ratio (NLR) for Predicting Clinical Outcomes in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus: A Propensity Score Matching Analysis.中性粒细胞与淋巴细胞比值(NLR)对冠状动脉疾病合并2型糖尿病患者临床结局的预测作用:一项倾向评分匹配分析
Ther Clin Risk Manag. 2020 May 19;16:437-443. doi: 10.2147/TCRM.S244623. eCollection 2020.